Synthesis and activity of tumor-homing peptide iRGD and histone deacetylase inhibitor valproic acid conjugate

被引:12
作者
Peng, Zheng-Hong [1 ]
Kopecek, Jindrich [1 ,2 ]
机构
[1] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, CCCD, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA
基金
美国国家卫生研究院;
关键词
Histone deacetylase inhibitor; Valproic acid; Cell penetrating peptide; Cell cycle arrest; PROSTATE-CANCER CELLS; PENETRATING PEPTIDE; IN-VITRO; DELIVERY; EXPRESSION; INTEGRINS; EFFICACY; DESIGN; DRUGS; VIVO;
D O I
10.1016/j.bmcl.2014.03.006
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this Letter, we present a concise strategy to prepare a conjugate of the tumor homing peptide iRGD and histone deacetylase inhibitor valproic acid, VPA-GFLG-iRGD. The conjugate VPA-GFLG-iRGD and a mixture of VPA and GFLG-iRGD have shown similar cytotoxicity against DU-145 prostate cancer cells. However, the treatment of DU-145 cells with conjugate VPA-GFLG-iRGD resulted in a decreased percentage of cells in the G2 phase, whereas the exposure of a mixture of VPA and GFLG-iRGD led to an increased percentage of cells in the G2 phase. We also found that GFLG-iRGD possessed cytotoxicity at the tested concentrations. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1928 / 1933
页数:6
相关论文
共 27 条
[1]   αv integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells [J].
Cruet-Hennequart, S ;
Maubant, S ;
Luis, J ;
Gauduchon, P ;
Staedel, C ;
Dedhar, S .
ONCOGENE, 2003, 22 (11) :1688-1702
[2]   Design of pH responsive clickable prodrugs applied to histone deacetylase inhibitors: A new strategy for anticancer therapy [J].
Delatouche, Regis ;
Denis, Iza ;
Grinda, Marion ;
El Bahhaj, Fatima ;
Baucher, Estelle ;
Collette, Floraine ;
Heroguez, Valerie ;
Gregoire, Marc ;
Blanquart, Christophe ;
Bertrand, Philippe .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 85 (03) :862-872
[3]   Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters [J].
Dubikovskaya, Elena A. ;
Thorne, Steve H. ;
Pillow, Thomas H. ;
Contag, Christopher H. ;
Wender, Paul A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (34) :12128-12133
[4]   Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells [J].
Fronsdal, K ;
Saatcioglu, F .
PROSTATE, 2005, 62 (03) :299-306
[5]   Intracellular cargo delivery by an octaarginine transporter adapted to target prostate cancer cells through cell surface protease activation [J].
Goun, Elena A. ;
Shinde, Rajesh ;
Dehnert, Karen W. ;
Adams-Bond, Angie ;
Wender, Paul A. ;
Contag, Christopher H. ;
Franc, Benjamin L. .
BIOCONJUGATE CHEMISTRY, 2006, 17 (03) :787-796
[6]   Upregulation and nuclear recruitment of HDACI in hormone refractory prostate cancer [J].
Halkidou, K ;
Gaughan, L ;
Cook, S ;
Leung, HY ;
Neal, DE ;
Robson, CN .
PROSTATE, 2004, 59 (02) :177-189
[7]   Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity [J].
Koren, Erez ;
Apte, Anjali ;
Jani, Ankur ;
Torchilin, Vladimir P. .
JOURNAL OF CONTROLLED RELEASE, 2012, 160 (02) :264-273
[8]   Blockade of αvβ3 and αvβ5 integrins by RGD mimetics induces anoikis and not integrin-mediated death in human endothelial cells [J].
Maubant, Sylvie ;
Saint-Dizier, Dominique ;
Boutillon, Morgane ;
Perron-Sierra, Francoise ;
Casara, Patrick J. ;
Hickman, John A. ;
Tucker, Gordon C. ;
Van Obberghen-Schilling, Ellen .
BLOOD, 2006, 108 (09) :3035-3044
[9]   Cyclic RGD-Linked Polymeric Micelles for Targeted Delivery of Platinum Anticancer Drugs to Glioblastoma through the Blood-Brain Tumor Barrier [J].
Miura, Yutaka ;
Takenaka, Tomoya ;
Toh, Kazuko ;
Wu, Shourong ;
Nishihara, Hiroshi ;
Kano, Mitsunobu R. ;
Ino, Yasushi ;
Nomoto, Takahiro ;
Matsumoto, Yu ;
Koyama, Hiroyuki ;
Cabral, Horacio ;
Nishiyama, Nobuhiro ;
Kataoka, Kazunori .
ACS NANO, 2013, 7 (10) :8583-8592
[10]   Design of a tumor-homing cell-penetrating peptide [J].
Myrberg, Helena ;
Zhang, Lianglin ;
Maee, Maarja ;
Langel, Uelo .
BIOCONJUGATE CHEMISTRY, 2008, 19 (01) :70-75